These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
381 related articles for article (PubMed ID: 31181622)
1. Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells. Mrkvová Z; Uldrijan S; Pombinho A; Bartůněk P; Slaninová I Molecules; 2019 Jun; 24(11):. PubMed ID: 31181622 [TBL] [Abstract][Full Text] [Related]
2. A small molecule drug promoting miRNA processing induces alternative splicing of MdmX transcript and rescues p53 activity in human cancer cells overexpressing MdmX protein. Valianatos G; Valcikova B; Growkova K; Verlande A; Mlcochova J; Radova L; Stetkova M; Vyhnakova M; Slaby O; Uldrijan S PLoS One; 2017; 12(10):e0185801. PubMed ID: 28973015 [TBL] [Abstract][Full Text] [Related]
3. Induction of p53 expression and apoptosis by a recombinant dual-target MDM2/MDMX inhibitory protein in wild-type p53 breast cancer cells. Geng QQ; Dong DF; Chen NZ; Wu YY; Li EX; Wang J; Wang SM Int J Oncol; 2013 Dec; 43(6):1935-42. PubMed ID: 24126697 [TBL] [Abstract][Full Text] [Related]
4. AXL receptor signalling suppresses p53 in melanoma through stabilization of the MDMX-MDM2 complex. de Polo A; Luo Z; Gerarduzzi C; Chen X; Little JB; Yuan ZM J Mol Cell Biol; 2017 Apr; 9(2):154-165. PubMed ID: 27927748 [TBL] [Abstract][Full Text] [Related]
5. Elevated MDM2 boosts the apoptotic activity of p53-MDM2 binding inhibitors by facilitating MDMX degradation. Xia M; Knezevic D; Tovar C; Huang B; Heimbrook DC; Vassilev LT Cell Cycle; 2008 Jun; 7(11):1604-12. PubMed ID: 18520179 [TBL] [Abstract][Full Text] [Related]
6. Efficient p53 activation and apoptosis by simultaneous disruption of binding to MDM2 and MDMX. Hu B; Gilkes DM; Chen J Cancer Res; 2007 Sep; 67(18):8810-7. PubMed ID: 17875722 [TBL] [Abstract][Full Text] [Related]
7. Novel simplified yeast-based assays of regulators of p53-MDMX interaction and p53 transcriptional activity. Leão M; Gomes S; Soares J; Bessa C; Maciel C; Ciribilli Y; Pereira C; Inga A; Saraiva L FEBS J; 2013 Dec; 280(24):6498-507. PubMed ID: 24119020 [TBL] [Abstract][Full Text] [Related]
8. Context-dependent roles of MDMX (MDM4) and MDM2 in breast cancer proliferation and circulating tumor cells. Gao C; Xiao G; Piersigilli A; Gou J; Ogunwobi O; Bargonetti J Breast Cancer Res; 2019 Jan; 21(1):5. PubMed ID: 30642351 [TBL] [Abstract][Full Text] [Related]
9. DIMP53-1: a novel small-molecule dual inhibitor of p53-MDM2/X interactions with multifunctional p53-dependent anticancer properties. Soares J; Espadinha M; Raimundo L; Ramos H; Gomes AS; Gomes S; Loureiro JB; Inga A; Reis F; Gomes C; Santos MMM; Saraiva L Mol Oncol; 2017 Jun; 11(6):612-627. PubMed ID: 28296148 [TBL] [Abstract][Full Text] [Related]
10. A tryptophanol-derived oxazolopiperidone lactam is cytotoxic against tumors via inhibition of p53 interaction with murine double minute proteins. Soares J; Raimundo L; Pereira NA; dos Santos DJ; Pérez M; Queiroz G; Leão M; Santos MM; Saraiva L Pharmacol Res; 2015; 95-96():42-52. PubMed ID: 25814188 [TBL] [Abstract][Full Text] [Related]
11. Affinity-based screening of MDM2/MDMX-p53 interaction inhibitors by chemical array: identification of novel peptidic inhibitors. Noguchi T; Oishi S; Honda K; Kondoh Y; Saito T; Kubo T; Kaneda M; Ohno H; Osada H; Fujii N Bioorg Med Chem Lett; 2013 Jul; 23(13):3802-5. PubMed ID: 23726030 [TBL] [Abstract][Full Text] [Related]
13. Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase. Okamoto K; Taya Y; Nakagama H FEBS Lett; 2009 Sep; 583(17):2710-4. PubMed ID: 19619542 [TBL] [Abstract][Full Text] [Related]
14. The Roles of MDM2 and MDMX in Cancer. Karni-Schmidt O; Lokshin M; Prives C Annu Rev Pathol; 2016 May; 11():617-44. PubMed ID: 27022975 [TBL] [Abstract][Full Text] [Related]
15. A Fusion Protein of the p53 Transaction Domain and the p53-Binding Domain of the Oncoprotein MdmX as an Efficient System for High-Throughput Screening of MdmX Inhibitors. Chen R; Zhou J; Qin L; Chen Y; Huang Y; Liu H; Su Z Biochemistry; 2017 Jun; 56(25):3273-3282. PubMed ID: 28581721 [TBL] [Abstract][Full Text] [Related]
16. Human epidermal growth factor receptor 4 (Her4) Suppresses p53 Protein via Targeting the MDMX-MDM2 Protein Complex: IMPLICATION OF A NOVEL MDMX SER-314 PHOSPHOSITE. Gerarduzzi C; de Polo A; Liu XS; El Kharbili M; Little JB; Yuan ZM J Biol Chem; 2016 Dec; 291(50):25937-25949. PubMed ID: 27777309 [TBL] [Abstract][Full Text] [Related]
18. Peli1 Modulates the Subcellular Localization and Activity of Mdmx. Li D; Tavana O; Sun SC; Gu W Cancer Res; 2018 Jun; 78(11):2897-2910. PubMed ID: 29523541 [TBL] [Abstract][Full Text] [Related]
19. Interplay between MDM2, MDMX, Pirh2 and COP1: the negative regulators of p53. Wang L; He G; Zhang P; Wang X; Jiang M; Yu L Mol Biol Rep; 2011 Jan; 38(1):229-36. PubMed ID: 20333547 [TBL] [Abstract][Full Text] [Related]
20. Medicinal Chemistry Strategies to Disrupt the p53-MDM2/MDMX Interaction. Lemos A; Leão M; Soares J; Palmeira A; Pinto M; Saraiva L; Sousa ME Med Res Rev; 2016 Sep; 36(5):789-844. PubMed ID: 27302609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]